South Africa's Aspen plans to buy infant nutritional business from Nestle

JOHANNESBURG Thu Apr 18, 2013 3:09am EDT

A Nestle logo is printed by a 3D printer during a display for the inauguration of the system technology centre for the design, development and deployment of their products in Orbe March 25, 2013. REUTERS/Denis Balibouse

A Nestle logo is printed by a 3D printer during a display for the inauguration of the system technology centre for the design, development and deployment of their products in Orbe March 25, 2013.

Credit: Reuters/Denis Balibouse

Related Topics

JOHANNESBURG (Reuters) - South Africa's Aspen Pharmacare (APNJ.J) has plans to buy Nestle South Africa's infant nutritional business for $215 million, the company said on Thursday.

The deal gives it certain rights to intellectual property licenses, net assets and shares currently conducted by Pfizer.

(Reporting by Sherilee Lakmidas)

(The story corrects value of acquisition)

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.